Preferential inactivation of the C5 convertase of the alternative complement pathway by factor I and membrane cofactor protein (MCP)
- 31 October 1991
- journal article
- Published by Elsevier in Molecular Immunology
- Vol. 28 (10), 1137-1147
- https://doi.org/10.1016/0161-5890(91)90029-j
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Proteolytic elimination of decay-accelerating factor (DAF): Lytic abnormality coincides with removal of DAF in papain-treated human erythrocytesMolecular Immunology, 1990
- Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.The Journal of Experimental Medicine, 1988
- Separation of self from non-self in the complement systemImmunology Today, 1987
- Covalent association of C3b with C4b within C5 convertase of the classical complement pathway.The Journal of Experimental Medicine, 1987
- Fast and efficient method for detection and estimation of proteinsBiochemical and Biophysical Research Communications, 1985
- Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria.The Journal of Experimental Medicine, 1985
- Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.The Journal of Experimental Medicine, 1984
- Mechanism of action of the C3b inactivator: Requiremen for a high molecular weight cofactor (C3b-C4bINA cofactor) and production of a new C3b derivative (C3b′)Immunochemistry, 1977
- Third component of human complement: purification from plasma and physicochemical characterizationBiochemistry, 1976
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970